Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK3772701 in Uncomplicated P. Falciparum Malaria
NCT07545681Phase 2Not yet recruiting
- Sponsor
- GSK
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 2 trial of MMV367 in Malaria, sponsored by GSK. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
MMV367
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT07545681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07545681.